Nutrient sensing, signaling and ageing: the role of IGF-1 and mTOR in ageing and age-related disease
SC Johnson - Biochemistry and Cell Biology of Ageing: Part I …, 2018 - Springer
Nutrient signaling through insulin/IGF-1 was the first pathway demonstrated to regulate
ageing and age-related disease in model organisms. Pharmacological or dietary …
ageing and age-related disease in model organisms. Pharmacological or dietary …
Sarcopenia: tilting the balance of protein homeostasis
KT Tan, STJ Ang, SY Tsai - Proteomics, 2020 - Wiley Online Library
Sarcopenia, defined as age‐associated decline of muscle mass and function, is a risk factor
for mortality and disability, and comorbid with several chronic diseases such as type II …
for mortality and disability, and comorbid with several chronic diseases such as type II …
Shape-based machine learning models for the potential novel COVID-19 protease inhibitors assisted by molecular dynamics simulation
A Nayarisseri, R Khandelwal… - Current topics in …, 2020 - ingentaconnect.com
Background: The vast geographical expansion of novel coronavirus and an increasing
number of COVID-19 affected cases have overwhelmed health and public health services …
number of COVID-19 affected cases have overwhelmed health and public health services …
[HTML][HTML] An in silico approach to identify high affinity small molecule targeting m-TOR inhibitors for the clinical treatment of breast cancer
K Patidar, U Panwar, S Vuree, J Sweta… - Asian Pacific journal …, 2019 - ncbi.nlm.nih.gov
Breast cancer is the most frequent malignancy among women. It is a heterogeneous disease
with different subtypes defined by its hormone receptor. A hormone receptor is mainly …
with different subtypes defined by its hormone receptor. A hormone receptor is mainly …
Structure-based virtual screening for the identification of high affinity compounds as potent VEGFR2 inhibitors for the treatment of renal cell carcinoma
Introduction: Renal Cell Carcinoma is a common type of renal cancer-causing deaths
worldwide which is characterized by sustained angiogenesis. VEGF and its receptors play a …
worldwide which is characterized by sustained angiogenesis. VEGF and its receptors play a …
[HTML][HTML] Design of PD-L1 inhibitors for lung cancer
The progression of lung cancer is associated with inactivation of programmed cell death
protein 1, abbreviated as PD-1 which regulates the suppression of the body's immune …
protein 1, abbreviated as PD-1 which regulates the suppression of the body's immune …
An in silico investigation of potential EGFR inhibitors for the clinical treatment of colorectal cancer
M Majhi, MA Ali, A Limaye, K Sinha… - Current topics in …, 2018 - ingentaconnect.com
Colorectal cancer possesses the third highest diagnostic rate and is the second leading
cause of cancer death in the USA as reported by NIH. Epidermal Growth Factor Receptor …
cause of cancer death in the USA as reported by NIH. Epidermal Growth Factor Receptor …
Experimental and computational approaches to improve binding affinity in chemical biology and drug discovery
A Nayarisseri - Current Topics in Medicinal Chemistry, 2020 - ingentaconnect.com
Drug discovery is one of the most complicated processes and establishment of a single drug
may require multidisciplinary attempts to design efficient and commercially viable drugs. The …
may require multidisciplinary attempts to design efficient and commercially viable drugs. The …
[HTML][HTML] Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis
D Jain, T Udhwani, S Sharma, A Gandhe… - …, 2019 - ncbi.nlm.nih.gov
Multiple cytokines play a pivotal role in the pathogenesis of Rheumatoid Arthritis by inducing
intracellular signaling and it is known that the members of the Janus kinase (JAK) family are …
intracellular signaling and it is known that the members of the Janus kinase (JAK) family are …
[HTML][HTML] Virtual screening of IL-6 inhibitors for idiopathic arthritis
P Shukla, R Khandelwal, D Sharma, A Dhar… - …, 2019 - ncbi.nlm.nih.gov
Juvenile idiopathic arthritis (JIA) is a heterogeneous disease characterized by the arthritis of
unknown origin and IL6 is a known target for JIA. 20 known inhibitors towards IL-6 were …
unknown origin and IL6 is a known target for JIA. 20 known inhibitors towards IL-6 were …